Search Results - "Abdelrahman, Aziza E"

Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer by Abdelrahman, Aziza E., Rashed, Hayam E., Elkady, Ehab, Elsebai, Eman A., El-Azony, Ahmed, Matar, Ihab

“…Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease which has an unpredictable risk of progression to muscle-invasive bladder cancer (MIBC)…”
Get full text

Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer by Abdelrahman, Aziza E, Rashed, Hayam E, Abdelgawad, Mohamed, Abdelhamid, Mohamed I

“…Highlights • EGFR and CK5/6 are adverse prognostic markers in TNBC. • EGFR and CK5/6 expression are associated with poor clinical and pathological response to…”
Get full text

Protective effect of cerium oxide nanoparticles on cisplatin and oxaliplatin primary toxicities in male albino rats by Abdelhamid, Amira Mohamed, Mahmoud, Shireen Sami, Abdelrahman, Aziza E., Said, Nelly Mohamed, Toam, Mostafa, Samy, Walaa, Amer, Marwa AbdEl-Moniem

“…Cisplatin and oxaliplatin are widely used anticancer drugs. Their use is restricted by their dose-limiting side effects: nephrotoxicity and neurotoxicity,…”
Get full text

Prognostic value of NOTCH1 and OCT4 in gastric carcinoma by Ibrahim, Doaa, Elsebai, Eman, Fayed, Alaa, Abdelrahman, Aziza

“…Background: NOTCH1 pathway activation has been recently described to be a key player in gastric carcinogenesis, enhance the survival and proliferation of…”
Get full text

Clinicopathological significance of protein disulphide isomerase A3 and phosphorylated signal transducer and activator of transcription 3 in cervical carcinoma by Abdullatif, Asmaa, Abdelrahman, Aziza E, Bakry, Adel, Gharieb, Shimaa A, Ramadan, Mohamed Sh, Wasfy, Mohamed A, Abdelwanis, Abdelfatah H, Fouad, Enas M

“…Death in cervical cancer patients is usually due to invasion and metastasis due to the aggressive nature of the tumour. Therefore, it is critical to identify…”
Get full text

EZH2, Endothelin-1, and CD34 as Biomarkers of Aggressive Cervical Squamous Cell Carcinoma: An Immunohistochemical Study by Fathy, Anan, Abdelrahman, Aziza E

“…Cervical cancer has an increasing incidence in developing countries with a predominance of squamous cell carcinoma. In this work, we aimed to analyze the role…”
Get full text

Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study by Abdelrahman, Aziza E, Arafa, Shimaa A, Ahmed, Ragab A

“…There is an urgent need to identify molecular biomarkers rather than clinical markers to distinguish aggressive prostate cancer from the indolent majority for…”
Get full text

Clinicopathological features and treatment challenges in triple negative breast cancer patients: a retrospective cohort study by Elwan, Amira, Abdelrahman, Aziza E., Alnagar, Ahmed A., Abdelhamid, Mohamed I, Nawar, Nashwa

“…Objective: As the genetic and molecular profiles of triple negative breast carcinoma (TNBC) are elucidated, multiple therapeutic targets have been produced…”
Get full text

Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study by Rashed, Hayam E, Abdelrahman, Aziza E, Abdelgawad, Mohamed, Balata, Safa, Shabrawy, Mohamed El

“…Programmed cell death ligand-1 interacts with the immune receptors on the surface of CD8+ tumor infiltrating lymphocytes and PD-1, thereby blocking its…”
Get full text

Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer by Abdelrahman, Aziza E., El-azony, Ahmed, Elsebai, Eman, Ibrahim, Hanaa M.

“…The potentiation and activation of Wnt signaling pathways are now assumed to mediate the self-renewal and proliferation of colon cancer stem cells that are…”
Get full text

Clinicopathological significance of the immunologic signature (PDL1, FOXP3+ Tregs, TILs) in early stage triple-negative breast cancer treated with neoadjuvant chemotherapy by Abdelrahman, Aziza E., Rashed, Hayam E., MostafaToam, Omar, Ayman, Abdelhamid, Mohamed I., Matar, Ihab

“…Patients with breast cancer are appropriate candidates for neoadjuvant chemotherapy (NAC) to facilitate conservative surgery. The chemotherapeutic agents may…”
Get full text

Clinicopathological Impact of FOXM1 and MMP-9 Immunohistochemical Expression in Different Grades of Intracranial Meningioma by Ibrahim, Hanaa M, Abdelrahman, Aziza E, Elwan, Amira, Gharieb, Shimaa A, Refaat, Mohammed, Elmesallamy, Wael, Salem, Amira A

“…To find predictive biomarkers for recurrence and progression of meningioma. Despite great advances in meningioma treatment, the prognosis remained unfavorable…”
Get full text

Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study by Ibrahim, Hanaa M., Abdelrahman, Aziza E., Elwan, Amira, Bakry, Adel, Fahmy, Moamna M., Abdelhamid, Mohamed I., Abdelwanis, Abdelfatah H., Fouad, Enas M.

“…There is a cellular crosstalk between Wnt/β-catenin and Hippo/Yes-related protein 1 signaling paths in colon cancer (CC) which promotes EMT processes that…”
Get full text

p53, Pirh2, and L1CAM as Promising Prognostic Biomarkers of Endometrial Carcinoma: An Immunohistochemical and Genetic Study by Abdelrahman, Aziza E., Salem, Amira, Al Attar, Ahmed Z., Elsebai, Eman, Samy, Walaa, Ibrahim, Mohamed A., Ibrahim, Hanaa M.

“…Endometrial cancer (EC) is the most common gynecologic cancer and the current methods for the prediction of its prognosis and treatment response are…”
Get full text

Clinicopathologic Impact of NANOG, ZEB1, and EpCAM Biomarkers on Prognosis of Serous Ovarian Carcinoma by Ibrahim, Hanaa M, Abdelrahman, Aziza E, Elsebai, Eman, Gharieb, Shimaa A, Fahmy, Moamna M, Ramadan, Mohamed S H, Wasfy, Mohamed A, Abdullatif, Asmaa

“…Serous ovarian carcinoma (SOC) is a biologically heterogeneous with different genomic and molecular profiles, beside clinical response to the chemotherapy with…”
Get full text

MIR-379-5p Expression in Endometrial Cancer and Its Correlation with ROR1 Expression by Mosaad, Hala, Abdelrahman, Aziza E, Abdullatif, Asmaa, Lashin, Mohamed El-Bakry, Ramadan, Mohamed S H, El-Azony, Ahmed, Hussien, Marwa H S

“…To asses miR-379-5p expression in endometrial cancer (EC) and its correlation with ROR1 expression and to investigate the relation between miR-379-5p and ROR1…”
Get full text

Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy by Abdelrahman, Aziza E., Fathy, Anan, Elsebai, Eman A., Nawar, Nashwa, Etman, Waleed M.

“…Chemoresistance is the major obstacle to effective treatment in patients with serous ovarian carcinoma (SOC), which frequently related to the failure of…”
Get full text

Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study by Abdelrahman, Aziza E, Arafa, Shimaa A, Ahmed, Ragab A

“…There is an urgent need to identify molecular biomarkers rather than clinical markers to distinguish aggressive prostate cancer from the indolent majority for…”
Get more information

C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma by Mohammed, Amrallah A, Rashed, Hayam E, Abdelrahman, Aziza E, Obaya, Ahmed A, Toam, Mostafa, Abdel Nour, Hanim M, Abdelhamid, Mohamed I, Elsayed, Fifi Mostafa

“…Background: Due to lack of availability of gene expression profiling (GEP) for most developing countries and clinicians; the immunohistochemistry (IHC) is…”
Get full text

The clinicopathological significance of CD133 and Sox2 in astrocytic glioma by Abdelrahman, Aziza E, Ibrahim, Hanaa M, Elsebai, Eman A, Ismail, Eman I, Elmesallamy, Wael

“…The treatment strategies of astrocytoma have not changed considerably due to the restricted appreciation of its biology. This study aimed to evaluate the…”
Get more information